Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing.

On May 4, 2009, NYSE Amex notified IGI Laboratories, Inc. (the "Company") that it had determined that the Company has made a reasonable demonstration of its ability to regain compliance with Sections 1003(a)(ii) and (iii) of the Company Guide in accordance with Section 1009 and therefore granted the Company an extension from May 6, 2009 until May 31, 2009 to regain compliance with these continued listing standards.

A copy of the Company's press release regarding receipt of the extension is attached hereto as Exhibit 99.1 and is incorporated herein by reference.

Item 9.01.